MD
Neurology
Dr. Francesca R. Bagnato, MD
|
|
Give Review
Francesca R. Bagnato is an expert in the field of Neurology. Francesca Bagnato is a published physician as well. She has 61 publications published. The latest was: Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting multiple sclerosis.
Publications
- Diffuse and Focal Corticospinal Tract Disease and Its Impact on Patient Disability in Multiple Sclerosis.
- Visualizing iron in Multiple sclerosis.
- Cognitive Impairment and Its Relation to Imaging Measures in Multiple Sclerosis: A Study Using a Computerized Battery.
- 7 tesla magnetic resonance imaging to detect cortical pathology in Multiple sclerosis.
- Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments.
- Chronic lymphocytic leukemia complicated by progressive multifocal leukoencephalopathy without apparent immunodepression.
- Antinuclear antibodies and response to IFNbeta-1a therapy in relapsing-remitting Multiple sclerosis.
- Contrast-enhanced magnetic resonance activity in relapsing remitting Multiple sclerosis patients: a short term natural history study.
- Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting Multiple sclerosis patients treated with IFN beta-...
- Determinants of Gd-enhanced MRI response to IFN-beta-1a treatment in relapsing-remitting Multiple sclerosis.
- Development of neutralizing antibodies in patients with relapsing-remitting Multiple sclerosis treated with IFN-beta1a.
- Comparison between the effects of neostigmine and ranitidine on interdigestive gastroduodenal motility of patients with gastroparesis.
- Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?
- A one-year study on the pharmacodynamic profile of interferon-beta1a in MS.
- MRI Brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.
- Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study.
- Beta-2 microglobulin and neopterin as markers of disease activity in Multiple sclerosis.
- Multidisciplinary approach for diagnosing syncope: a retrospective study on 521 outpatients.
- beta2-microglobulin serum level is not a marker of disease activity in Multiple sclerosis.
- Interferon-beta-1b effects on re-enhancing lesions in patients with Multiple sclerosis.
- Expression of biomarkers of interferon type I in patients suffering from chronic diseases.
- In vivo detection of cortical plaques by MR imaging in patients with Multiple sclerosis.
- Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.
- An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in Multiple sclerosis.
- A case study on the effect of neutralizing antibodies to interferon beta 1b in Multiple sclerosis patients followed for 3 years with monthly imaging.
- Thalamic involvement and its impact on clinical disability in patients with Multiple sclerosis: a diffusion tensor imaging study at 3T.
- Ring and nodular Multiple sclerosis lesions: a retrospective natural history study.
- Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced Multiple sclerosis-induced damage.
- Multisequence-imaging protocols to detect cortical lesions of patients with Multiple sclerosis: observations from a post-mortem 3 Tesla imaging study.
- Tracking iron in Multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.
- Chronic Multiple sclerosis lesions: characterization with high-field-strength MR imaging.
- Lesions by tissue specific imaging characterize Multiple sclerosis patients with more advanced disease.
- Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis.
- Fractal analysis reveals reduced complexity of retinal vessels in CADASIL.
- Painful and involuntary Multiple sclerosis.
- T1 cortical hypointensities and their association with cognitive disability in Multiple sclerosis.
- Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with Multiple sclerosis.
- Relationship of cortical atrophy to fatigue in patients with Multiple sclerosis.
- Uncovering and characterizing Multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
- Heterogeneity in response to interferon beta in patients with Multiple sclerosis: a 3-year monthly imaging study.
- The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with Multiple sclerosis.
- The effect of interferon-beta on black holes in patients with Multiple sclerosis.
- Pharmacodynamics of interferon beta in Multiple sclerosis patients with or without serum neutralizing antibodies.
- Neutralising antibodies to IFN-beta in patients with Multiple sclerosis.
- Effect of MRI coregistration on serial short-term Brain volume changes in multiple sclerosis.
- Clinical and imaging metrics for monitoring disease progression in patients with Multiple sclerosis.
- A novel assay to detect low-titred antibodies to interferon beta in Multiple sclerosis patients.
- Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis.
- Considerations on the development of serum antibodies to interferon-beta.
- Neutralizing antibodies against endogenous interferon in myasthenia gravis patients.
- Effects of interferon beta-1b on black holes in Multiple sclerosis over a 6-year period with monthly evaluations.
- Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
- Short-term Brain atrophy changes in relapsing-remitting multiple sclerosis.
- Corticosteroids treatment.
- Pharmacological methods to overcome IFN-beta antibody formation in the treatment of Multiple sclerosis.
- Evolution of T1 black holes in patients with Multiple sclerosis imaged monthly for 4 years.
- The role of nonconventional magnetic resonance imaging techniques in demyelinating disorders.
- Proteolytic balance in patients with Multiple sclerosis during interferon treatment.
- Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in Multiple sclerosis.
- Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting Multiple sclerosis patients treated with different IFN-beta preparations.
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Ataxia
- Brain Aneurysm
- Cerebral Artery Thrombosis
- Cerebral Hemorrhage
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
University of Maryland -
Sapienza University of Rome
Helpful Reviews
Similar Doctors
|
|
Dr. Earl J. Metter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitrios Kapogiannis, MD
This Doctor is OpenDoctor Recommended.
|